Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines
- PMID: 21819638
- DOI: 10.1017/S0031182011001120
Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines
Abstract
Mathematical models predict that the future of epidemics of drug-resistant pathogens depends in part on the competitive fitness of drug-resistant strains. Considering metacyclogenesis (differentiation process essential for infectivity) as a major contributor to the fitness of Leishmania donovani, we tested its relationship with pentavalent antimony (SbV) resistance in clinical lines. Different methods for the assessment of metacyclogenesis were cross-validated: gene expression profiling (META1 and SHERP), morphometry (microscopy and FACS), in vitro infectivity to macrophages and resistance to complement lysis. This was done on a model constituted by 2 pairs of reference strains cloned from a SbV-resistant and -sensitive isolate. We selected the most adequate parameter and extended the analysis of metacyclogenesis diversity to a sample of 20 clinical lines with different in vitro susceptibility to the drug. The capacity of metacyclogenesis, as measured by the complement lysis test, was shown to be significantly higher in SbV-resistant clinical lines of L. donovani than in SbV-sensitive lines. Together with other lines of evidence, it is concluded that L. donovani constitutes a unique example and model of drug-resistant pathogens with traits of increased fitness. These findings raise a fundamental question about the potential risks of selecting more virulent pathogens through massive chemotherapeutic interventions.
Similar articles
-
Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.Parasitology. 2007 Aug;134(Pt 9):1175-84. doi: 10.1017/S0031182007002569. Epub 2007 Mar 16. Parasitology. 2007. PMID: 17362540
-
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12. J Antimicrob Chemother. 2010. PMID: 20067981
-
Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.Biochem Biophys Res Commun. 2013 Nov 1;440(4):646-51. doi: 10.1016/j.bbrc.2013.09.113. Epub 2013 Oct 5. Biochem Biophys Res Commun. 2013. PMID: 24103752
-
Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Crit Rev Microbiol. 2013 Nov;39(4):384-94. doi: 10.3109/1040841X.2012.716818. Epub 2012 Sep 6. Crit Rev Microbiol. 2013. PMID: 22950457 Review.
-
Drug resistance mechanisms in clinical isolates of Leishmania donovani.Indian J Med Res. 2006 Mar;123(3):411-22. Indian J Med Res. 2006. PMID: 16778320 Review.
Cited by
-
Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites.PLoS Pathog. 2024 Apr 24;20(4):e1012181. doi: 10.1371/journal.ppat.1012181. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38656959 Free PMC article.
-
Systematic Review of Treatment Failure and Clinical Relapses in Leishmaniasis from a Multifactorial Perspective: Clinical Aspects, Factors Associated with the Parasite and Host.Trop Med Infect Dis. 2023 Aug 29;8(9):430. doi: 10.3390/tropicalmed8090430. Trop Med Infect Dis. 2023. PMID: 37755891 Free PMC article. Review.
-
Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication.Parasit Vectors. 2021 Oct 28;14(1):556. doi: 10.1186/s13071-021-05057-x. Parasit Vectors. 2021. PMID: 34711290 Free PMC article.
-
Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.PLoS One. 2021 Oct 22;16(10):e0259009. doi: 10.1371/journal.pone.0259009. eCollection 2021. PLoS One. 2021. PMID: 34679130 Free PMC article.
-
Assessment of the Antileishmanial Potential of Cassia fistula Leaf Extract.ACS Omega. 2021 Jan 11;6(3):2318-2327. doi: 10.1021/acsomega.0c05629. eCollection 2021 Jan 26. ACS Omega. 2021. PMID: 33521470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources